AMSC Announces Proposed Public Offering of Common Stock
May 04, 2017 20:04 pm UTC| Business
DEVENS, Mass., May 04, 2017 -- American Superconductor Corporation (Nasdaq:AMSC), a global solutions provider serving the wind and power grid industry, today announced that it intends to offer and sell shares of its...
Avinger Announces First Quarter 2017 Results
May 04, 2017 20:04 pm UTC| Business
REDWOOD CITY, Calif., May 04, 2017 -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today reported results for the first quarter ended...
Avinger Announces First Quarter 2017 Results
May 04, 2017 20:04 pm UTC| Business
REDWOOD CITY, Calif., May 04, 2017 -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today reported results for the first quarter ended...
AMSC Announces Proposed Public Offering of Common Stock
May 04, 2017 20:04 pm UTC| Business
DEVENS, Mass., May 04, 2017 -- American Superconductor Corporation (Nasdaq:AMSC), a global solutions provider serving the wind and power grid industry, today announced that it intends to offer and sell shares of its...
Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 04, 2017 20:03 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., May 04, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic...
Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 04, 2017 20:03 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., May 04, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic...
Avinger Announces First Quarter 2017 Results
May 04, 2017 20:03 pm UTC| Business
REDWOOD CITY, Calif., May 04, 2017 -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today reported results for the first quarter ended...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes